These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 32058609)

  • 1. Model-Based Analysis of Cannabidiol Dose-Exposure Relationship and Bioavailability.
    Lim SY; Sharan S; Woo S
    Pharmacotherapy; 2020 Apr; 40(4):291-300. PubMed ID: 32058609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phase I study to assess the effect of food on the single dose bioavailability of the THC/CBD oromucosal spray.
    Stott CG; White L; Wright S; Wilbraham D; Guy GW
    Eur J Clin Pharmacol; 2013 Apr; 69(4):825-34. PubMed ID: 23052407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PTL401, a New Formulation Based on Pro-Nano Dispersion Technology, Improves Oral Cannabinoids Bioavailability in Healthy Volunteers.
    Atsmon J; Cherniakov I; Izgelov D; Hoffman A; Domb AJ; Deutsch L; Deutsch F; Heffetz D; Sacks H
    J Pharm Sci; 2018 May; 107(5):1423-1429. PubMed ID: 29287930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Food effect on pharmacokinetics of cannabidiol oral capsules in adult patients with refractory epilepsy.
    Birnbaum AK; Karanam A; Marino SE; Barkley CM; Remmel RP; Roslawski M; Gramling-Aden M; Leppik IE
    Epilepsia; 2019 Aug; 60(8):1586-1592. PubMed ID: 31247132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-Dose Pharmacokinetics of Oral Cannabidiol Following Administration of PTL101: A New Formulation Based on Gelatin Matrix Pellets Technology.
    Atsmon J; Heffetz D; Deutsch L; Deutsch F; Sacks H
    Clin Pharmacol Drug Dev; 2018 Sep; 7(7):751-758. PubMed ID: 29125702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and oral bioavailability of cannabidiol in horses after intravenous and oral administration with oil and micellar formulations.
    Sánchez de Medina A; Serrano-Rodríguez JM; Díez de Castro E; García-Valverde MT; Saitua A; Becero M; Muñoz A; Ferreiro-Vera C; Sánchez de Medina V
    Equine Vet J; 2023 Nov; 55(6):1094-1103. PubMed ID: 36624043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabidiol Bioavailability Is Nonmonotonic with a Long Terminal Elimination Half-Life: A Pharmacokinetic Modeling-Based Analysis.
    Kolli AR; Hoeng J
    Cannabis Cannabinoid Res; 2024 Apr; ():. PubMed ID: 38624257
    [No Abstract]   [Full Text] [Related]  

  • 8. Piperine-pro-nanolipospheres as a novel oral delivery system of cannabinoids: Pharmacokinetic evaluation in healthy volunteers in comparison to buccal spray administration.
    Cherniakov I; Izgelov D; Barasch D; Davidson E; Domb AJ; Hoffman A
    J Control Release; 2017 Nov; 266():1-7. PubMed ID: 28890215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase 1, randomized, pharmacokinetic trial of the effect of different meal compositions, whole milk, and alcohol on cannabidiol exposure and safety in healthy subjects.
    Crockett J; Critchley D; Tayo B; Berwaerts J; Morrison G
    Epilepsia; 2020 Feb; 61(2):267-277. PubMed ID: 32012251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Examination of a New Delivery Approach for Oral Cannabidiol in Healthy Subjects: A Randomized, Double-Blinded, Placebo-Controlled Pharmacokinetics Study.
    Patrician A; Versic-Bratincevic M; Mijacika T; Banic I; Marendic M; Sutlović D; Dujić Ž; Ainslie PN
    Adv Ther; 2019 Nov; 36(11):3196-3210. PubMed ID: 31512143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel Self-Emulsifying Drug Delivery System (SEDDS) Based on VESIsorb
    Knaub K; Sartorius T; Dharsono T; Wacker R; Wilhelm M; Schön C
    Molecules; 2019 Aug; 24(16):. PubMed ID: 31426272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Food effects on the formulation, dosing, and administration of cannabidiol (CBD) in humans: A systematic review of clinical studies.
    Silmore LH; Willmer AR; Capparelli EV; Rosania GR
    Pharmacotherapy; 2021 Apr; 41(4):405-420. PubMed ID: 33583102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects.
    Taylor L; Gidal B; Blakey G; Tayo B; Morrison G
    CNS Drugs; 2018 Nov; 32(11):1053-1067. PubMed ID: 30374683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of amorphous and lipid-based formulation strategies to increase the in vivo cannabidiol bioavailability in piglets.
    Koch N; Jennotte O; Bourcy Q; Lechanteur A; Deville M; Charlier C; Chiap P; Cardot JM; Evrard B
    Int J Pharm; 2024 May; 657():124173. PubMed ID: 38685441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic investigation of synthetic cannabidiol oral formulations in healthy volunteers.
    Izgelov D; Davidson E; Barasch D; Regev A; Domb AJ; Hoffman A
    Eur J Pharm Biopharm; 2020 Sep; 154():108-115. PubMed ID: 32634571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase I trial of the safety, tolerability and pharmacokinetics of cannabidiol administered as single-dose oil solution and single and multiple doses of a sublingual wafer in healthy volunteers.
    Hosseini A; McLachlan AJ; Lickliter JD
    Br J Clin Pharmacol; 2021 Apr; 87(4):2070-2077. PubMed ID: 33075170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of Pro NanoLipospheres (PNL) formulation containing natural absorption enhancers on the oral bioavailability of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) in a rat model.
    Cherniakov I; Izgelov D; Domb AJ; Hoffman A
    Eur J Pharm Sci; 2017 Nov; 109():21-30. PubMed ID: 28736128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of cannabidiol administered by 3 delivery methods at 2 different dosages to healthy dogs.
    Bartner LR; McGrath S; Rao S; Hyatt LK; Wittenburg LA
    Can J Vet Res; 2018 Jul; 82(3):178-183. PubMed ID: 30026641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of oral and intravenous cannabidiol and its antidepressant-like effects in chronic mild stress mouse model.
    Xu C; Chang T; Du Y; Yu C; Tan X; Li X
    Environ Toxicol Pharmacol; 2019 Aug; 70():103202. PubMed ID: 31173966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population Pharmacokinetics of Oral-Based Administration of Cannabidiol in Healthy Adults: Implications for Drug Development.
    Schultz HB; Hosseini A; McLachlan AJ; Reuter SE
    Cannabis Cannabinoid Res; 2023 Oct; 8(5):877-886. PubMed ID: 35443784
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.